# Larimar Therapeutics, Inc.: Form 8-K, filed Mar 24, 2025

- Company: [Larimar Therapeutics, Inc.](/companies/lrmr.md) (CIK 1374690)
- Form: 8-K
- Filed: 2025-03-24
- Accepted by EDGAR: Mar 24, 2025, 11:03 ET
- Period: 2025-03-24
- Accession: 0000950170-25-043487
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1374690/000095017025043487/lrmr-20250324.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1374690/000095017025043487/

## Items reported

- Item 2.02: Results of operations
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1374690/000095017025043487/lrmr-20250324.htm

Filed Mar 24, 2025.
Source: SEC EDGAR, the filing index for accession 0000950170-25-043487. Last ingested by Listed: Oct 24, 2026, 15:12 ET. No prices; not investment advice.